Table 1.
Participants’ characteristics.
| Variable (N = 32) | TM&ALND (N = 7) |
TM&SLNB (N = 8) | PM&ALND (N = 8) |
PM&SLNB (N = 9) |
P |
|---|---|---|---|---|---|
| Age (years) | 50.0 ± 11.1 | 53.6 ± 6.7 | 52.6 ± 7.9 | 52.8 ± 5.3 | 0.8 |
| Weight (kg) | 61.7 ± 8.3 | 66.5 ± 9.7 | 63.0 ± 7.9 | 58.4 ± 6.3 | 0.3 |
| BMI (kg/m2) | 23.3 ± 2.4 | 25.9 ± 3.7 | 25.5 ± 2.9 | 23.7 ± 1.9 | 0.2 |
| Muscle mass (kg) | 23.0 ± 2.3 | 23.6 ± 2.7 | 22.4 ± 2.3 | 20.8 ± 2.1 | 0.1 |
| Fat (%) | 30.1 ± 4.6 | 33.5 ± 5.5 | 33.0 ± 6.0 | 33.6 ± 6.6 | 0.6 |
| Stage (n, %) | |||||
| 0 | 0 | 3 (37.5%) | 2 (25%) | 4 (44.4%) | 0.6 |
| 1 | 1 (14.3%) | 3 (37.5%) | 2 (25%) | 5 (55.6%) | |
| 2 | 3 (42.9%) | 2 (25%) | 3 (37.5%) | 0 | |
| 3 | 3 (42.9%) | 0 | 1 (12.5%) | 0 | |
| Surgery site (n, %) | |||||
| Right | 5 (71.4%) | 4 (50%) | 4 (50%) | 6 (66.7%) | 0.8 |
| Dominant arm | 5 (71.4%) | 5 (62.5%) | 4 (50%) | 6 (66.7%) | 0.8 |
| Dissected LNs | 18 (9–25) | 7 (3–13) | 17.5 (10–26) | 9 (5–12) | <0.001 |
| Surgery duration (min) | |||||
| 108.9 ± 21.4 | 95 ± 16.1 | 122.3 ± 59.4 | 93.4 ± 40.0 | 0.5 | |
| Drainage removal day (n, %) | |||||
| 1st outpatient visit (POD 10) | 1 (14.3%) | 1 (12.5%) | 0 | 3 (33.3%) | 0.3 |
| 2nd outpatient visit (POD 17) | 6 (85.7%) | 4 (50%) | 4 (50%) | 4 (44.4%) | |
| 3rd outpatient visit (POD 24) | 0 | 3 (37.5%) | 3 (37.5%) | 1 (11.1%) | |
| 4th outpatient visit | 0 | 0 | 1 (12.5%) | 1 (11.1%) | |
| Neoadjuvant chemotherapy | |||||
| Yes | 6 (85.7%) | 1 (12.5%) | 7 (87.5%) | 1 (11.1%) | <0.001 |
Values are presented as Mean ± SD or n (%), Dissected LNs are showed median (minimum to maximum range). Abbreviation: Total mastectomy with axillary lymph node dissection; TM with ALND, Total mastectomy with sentinel node biopsy; TM with SLNB, Partial mastectomy with axillary node dissection; PM with ALND, Partial mastectomy with sentinel node biopsy; PM with SLNB, Lymph Nodes; LNs, Postoperative Date; POD.